home / United States / Halozyme Therapeutics

Halozyme Therapeutics Market Cap

$7.57 B

-0.01 B

NASDAQ:HALO · April 16, 2025

Share price

$61.28

Enterprise Value

$8.50 B

Change (1-Year)

50.8%

Global Rank

#1970

Country Rank

#711

Regions

USA

Market cap

As of April 16, 2025, Halozyme Therapeutics (HALO) has a market cap of $7.57 billion USD. According to our data, Halozyme Therapeutics is ranked No.1970 in global market value.

Sector Rank:

Biotech #91 Pharmaceuticals #86

HALO Market Capitalization Growth

1 Years Growth:

50.8%

3 Years Growth:

37.4%

5 Years Growth:

201.3%

10 Years Growth:

274.8%

15 Years Growth:

594.2%

20 Years Growth:

3483.7%

Total Growth:

1250%

Halozyme Therapeutics Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Halozyme Therapeutics Market Cap CAGR Chart

Halozyme Therapeutics Market Cap History 2004 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$7.57 B	24.45%
Dec 31, 2024	$6.08 B	29.36%
Dec 29, 2023	$4.70 B	-35.04%
Dec 30, 2022	$7.24 B	41.51%
Dec 31, 2021	$5.12 B	-5.85%
Dec 31, 2020	$5.43 B	140.89%
Dec 31, 2019	$2.26 B	21.19%
Dec 31, 2018	$1.86 B	-27.79%
Dec 29, 2017	$2.58 B	105.06%
Dec 30, 2016	$1.26 B	-42.99%
Dec 31, 2015	$2.20 B	79.59%
Dec 31, 2014	$1.23 B	-35.62%
Dec 31, 2013	$1.91 B	123.40%
Dec 31, 2012	$0.85 B	-29.44%
Dec 30, 2011	$1.21 B	20.08%
Dec 31, 2010	$1.01 B	34.92%
Dec 31, 2009	$0.75 B	4.82%
Dec 31, 2008	$0.71 B	-21.24%
Dec 31, 2007	$0.90 B	-11.68%
Dec 29, 2006	$1.02 B	342.31%
Dec 30, 2005	$0.23 B	-17.27%
Dec 31, 2004	$0.28 B	100%

Similar Companies to Halozyme Therapeutics

Name	Market Cap	Market cap difference	Regions
Amgen AMGN	$158.77 B	0.132 B	USA
Biogen BIIB	$17.12 B	0.000 M	USA
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA
Vertex Pharmaceuticals VRTX	$128.67 B	-0.003 M	USA
BioMarin Pharmaceutical BMRN	$11.51 B	-0.000 M	USA
Incyte INCY	$11.31 B	0.000 M	USA
Alnylam Pharmaceuticals ALNY	$29.89 B	-0.001 M	USA
Sarepta Therapeutics SRPT	$5.28 B	-0.000 M	USA
Ionis Pharmaceuticals IONS	$4.51 B	0.000 M	USA
Moderna MRNA	$10.14 B	-0.001 M	USA
bluebird bio BLUE	$43.76 M	0.000 M	USA
CRISPR Therapeutics CRSP	$3.34 B	0.000 M	Switzerland
Editas Medicine EDIT	$0.11 B	0.000 M	USA

About Halozyme Therapeutics Inc.

Name

Halozyme Therapeutics, Inc.

Website

https://halozyme.com

Headquarters

San Diego,CA

symbol

HALO

CURRENCY

USD

country

United States

fullTimeEmployees

350

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

HALO Market Cap Formula

Market Cap	=	HALO Stock Price	*	HALO Shares Outstanding
	=	$61.28	*	0.12 B
	=	$7.57 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe